STSS Overview

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Wall Street analysts forecast STSS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for STSS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Sharps Technology Inc revenue for the last quarter amounts to 4.50M USD, decreased

Sharps Technology Inc. EPS for the last quarter amounts to -2.41 USD, decreased -99.67

Sharps Technology Inc (STSS) has 5 emplpoyees as of April 17 2026.

Today STSS has the market capitalization of 71.53M USD.